Abbott Laboratories’ MitraClip clamped leaking cardiac valves together more safely in a study than use of open-heart surgery to stitch the organ, potentially changing medical practice and reaping $1 billion in sales.

More:
Abbott Clip May See $1 Billion as Surgery Alternative (Update1)